Citations 2
PRX004 in variant amyloid transthyretin (ATTRv) amyloidosis: results of a phase 1, open-label, dose-escalation study
Suhr, Ole B. , Grogan, Martha , Silva, Ana , Karam, Chafic , Drachman, Brian , Zago, Wagner , Tripuraneni, Radhika , Kinney, Gene G. , Silva, Ana Martins da , Garcia-Pavia, Pablo , Drachman, Brian , Zago, Wagner , Tripuraneni, Radhika , Kinney, Gene G , Karam, Chafic
Amyloid | October 30, 2024 | Volume: 32 | Issue: 1 | Pages: 14-21
The mechanism of action, pharmacological characteristics, and clinical utility of the amyloid depleter birtamimab for the potential treatment of AL amyloidosis
Liedtke, Michaela , Zago, Wagner , Dolan, Phil, Kinney, Gene G. , Gertz, Morie A. , Gertz, Morie A , Palladini, Giovanni , Dolan, Philip J.
Leukemia & Lymphoma | April 11, 2024 | Volume: 65 | Issue: 8 | Pages: 1068-1078